Iterum Therapeutics plc

Ownership Transactions Reported by 9 Insiders

Symbol
ITRM on Nasdaq
Location
Fitzwilliam Court, 1 St Floor, Leeson Close, Dublin 2, Ireland

Insiders trading volume in the past year

Iterum Therapeutics plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ronald Hunt Director $483K Aug 6, 2024
Michael W. Dunne Director $308K +$94.1K +44% Aug 6, 2024
Corey N. Fishman Chief Executive Officer, Director $192K +$15.9K +9.01% Aug 6, 2024
Judith M. Matthews Chief Financial Officer $92.4K Mar 31, 2023
Sailaja Puttagunta Chief Medical Officer $75.3K Dec 1, 2023
David G. Kelly Director $52.4K Jun 15, 2022
Beth Hecht Director $26.4K Jun 15, 2023
Mark Chin Director $25.6K Jun 15, 2023
Brenton K. Ahrens Director $24.2K Dec 23, 2022

Recent Insider Transactions by Companies or Individuals for Iterum Therapeutics plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.